Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |